Page last updated: 2024-11-02

pantoprazole and Orphan Diseases

pantoprazole has been researched along with Orphan Diseases in 3 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Orphan Diseases: Rare diseases that have not been well studied.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krogulska, A1
Grzelak-Czachorowska, K1
Daniluk-Matraś, I1
Kuczyńska, R1
Szaflarska-Poplawska, A1
Dhakal, M1
Dhakal, OP1
Bhandari, D1
Gupta, A1
Aslan, M1
Celik, Y1
Karadas, S1
Olmez, S1
Cifci, A1

Reviews

1 review available for pantoprazole and Orphan Diseases

ArticleYear
Gastric xanthelasma: an unusual endoscopic finding.
    BMJ case reports, 2013, Oct-28, Volume: 2013

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Biopsy, Needle; Chronic Disease; Follow-Up Studies;

2013

Other Studies

2 other studies available for pantoprazole and Orphan Diseases

ArticleYear
Recurrent Nausea and Vomiting in a Teenager - A Rare Disease with Common Symptoms.
    Klinische Padiatrie, 2019, Volume: 231, Issue:1

    Topics: Adolescent; Anti-Ulcer Agents; Down Syndrome; Female; Gastric Outlet Obstruction; Gastritis; Gastros

2019
Liver hepatotoxicity associated with pantoprazole: a rare case report.
    Wiener klinische Wochenschrift, 2014, Volume: 126, Issue:11-12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Chemical and Drug Induce

2014